DMT and the Law: The Spirit Molecule's Legal Status

“DMT is Schedule I. It is also produced endogenously by the human body. The legal status of the body's own compound, when found in plant material, is one of the stranger features of modern drug law.”

DMT, dimethyltryptamine, is Schedule I under the US Controlled Substances Act. The scheduling covers both synthetic DMT and its natural occurrence in plants.

DMT is also detectable in human blood, urine, and cerebrospinal fluid under normal conditions. The body produces it endogenously through normal metabolic pathways. Rick Strassman's hypothesis, that the pineal gland may produce DMT during near-death experiences, deep meditation, and REM sleep, is not confirmed but has generated substantial research interest.

This creates a legal peculiarity: a compound the human body produces naturally is Schedule I when found in plant material. Psychotria viridis, one of two ayahuasca components, contains DMT and is thereby a controlled substance under the Federal Analogue Act, even though its DMT content is not active without the companion vine's MAO inhibitors.

Colorado's Proposition 122 decriminalized personal possession of DMT alongside psilocybin, ibogaine, and mescaline. Four US religious organizations hold DEA exemptions for ayahuasca (which contains DMT) under RFRA. All other ayahuasca use in the United States lacks federal legal protection, though prosecution is rare in practice.

McKenna described his DMT experiences in True Hallucinations as encounters with genuine entities in a real space, categorically different from the hallucinations drug law presupposes. The legal category 'controlled substance' encodes the assumption that the experience is distorted perception. This assumption is not settled by available evidence.

Sources

• Wikipedia Legal status of psychedelic drugs in the United States
• Mindmedicinelaw.com (2026)
• Strassman DMT The Spirit Molecule (2001)